Small Molecule Drugs

Small Molecule Drugs includes companies developing orally available or otherwise chemically synthesized medicines built from relatively low-molecular-weight compounds. This remains one of the broadest and most commercially important categories in biotech and pharma.

Why watch Small Molecule Drugs

This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.

Latest Small Molecule Drugs news

The latest feed items from companies currently grouped under Small Molecule Drugs.

1. 01
   2026-09-15 14:21 EST

   GSKGSK to acquire potential best-in-class T cell-engager (TCE) for multiple myeloma from Chimagen Biosciences

   Source: GSK plc

2. 02
   2026-09-13 19:30 EST

   GSKGSK presents positive registrational data to potentially expand Jideytro (zidesamtinib) to first-line ROS1-positive non-small cell lung cancer

   Source: GSK plc

3. 03
   2026-09-13 08:00 EST

   GSKRis-Rez reduced risk of death by 54% versus topotecan in patients with relapsed small cell lung cancer in China

   Source: GSK plc

4. 04
   2026-09-11 18:00 EST

   PHARFDA approves Pharming’s Joenja® as first treatment for children with APDS in the U.S.

   Source: Pharming Group

5. 05
   2026-09-10 07:00 EST

   GSKGSK’s Shingrix (Recombinant Zoster Vaccine) prefilled syringe presentation approved in Japan

   Source: GSK plc

6. 06
   2026-09-09 06:00 EST

   PHARPharming Group to participate in September investor conferences

   Source: Pharming Group

7. 07
   2026-09-08 12:00 EST

   PMVPPMV Pharmaceuticals Appoints Philip Herman as Chief Commercial Officer

   Source: PMV Pharmaceuticals

8. 08
   2026-09-02 20:05 EST

   ZNTLZentalis Pharmaceuticals to Participate in Upcoming Investor Conferences

   Source: Zentalis

9. 09
   2026-09-02 12:00 EST

   INVAInnoviva to Participate in Upcoming Investor Conferences

   Source: Innoviva

10. 10
    2026-09-01 21:15 EST

    ZNTLZentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    Source: Zentalis

11. 11
    2026-09-01 20:05 EST

    EXELExelixis to Webcast Fireside Chats as Part of Upcoming Investor Conferences in September

    Source: Exelixis

12. 12
    2026-09-01 11:00 EST

    BCRXBioCryst to Present at Upcoming Investor Conference

    Source: BioCryst Pharmaceuticals

13. 13
    2026-09-01 11:00 EST

    ENTAEnanta Pharmaceuticals to Participate in September Investor Conferences

    Source: Enanta Pharmaceuticals

14. 14
    2026-09-01 07:00 EST

    GSKGSK to advance mRNA seasonal flu vaccine candidate to phase III following positive phase II data

    Source: GSK plc

15. 15
    2026-09-01 03:04 EST

    PMVPPMV Pharma Announces Pricing of Oversubscribed $50 Million Public Offering of Securities

    Source: PMV Pharmaceuticals

16. 16
    2026-08-31 20:02 EST

    PMVPPMV Pharma Announces Proposed Public Offering of Securities

    Source: PMV Pharmaceuticals

17. 17
    2026-08-31 20:01 EST

    PMVPPMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial

    Source: PMV Pharmaceuticals

18. 18
    2026-08-31 18:30 EST

    EXELExelixis Announces Update on Patent Litigation Trial Appeal with MSN Laboratories

    Source: Exelixis

19. 19
    2026-08-24 07:01 EST

    GSKJemperli (dostarlimab) accepted for priority review by the US FDA for dMMR/MSI-H locally advanced rectal cancer

    Source: GSK plc

20. 20
    2026-08-24 07:00 EST

    GSKHibsago (bepirovirsen) approved in Japan as first and only functional cure for chronic hepatitis B

    Source: GSK plc

Companies in Small Molecule Drugs

20 companies tagged with Small Molecule Drugs.

Frequently Asked Questions